Good Manufacturing Practices (GMP) Audits in Human Drug Production Facilities

Good Manufacturing Practices (GMP) inspections in human drug production facilities are critical to ensure compliance with regulatory requirements and the production of safe, high-quality pharmaceuticals. Here are key points to consider during a GMP inspection:

1. Facility Design and Maintenance

• Cleanliness: The facility must be clean and organized, with defined zones for various stages of production.
• Layout: The design should minimize the risk of cross-contamination (e.g., separate areas for raw materials, production, and packaging).
• Maintenance: Equipment, walls, floors, and ceilings should be well-maintained and made of materials that are easy to clean and resistant to chemicals.

2. Quality Management System (QMS)

• Documentation: Ensure that all manufacturing processes, quality controls, and deviations are documented clearly.
• Corrective and Preventive Actions (CAPA): Inspect how the facility manages deviations and corrective actions.
• Change Control: Verify if any changes in production or processes are documented and assessed for risks before implementation.

3. Personnel Training and Hygiene

• Training: Staff should be well-trained, with regular updates on procedures, safety protocols, and GMP regulations.
• Personal Hygiene: Inspect staff hygiene practices, including hand-washing stations, protective clothing, and policies regarding food, drink, and personal items in production areas.

4. SOPs and Batch Records

• Standard Operating Procedures (SOPs): Ensure that clear, updated SOPs are in place and are being followed.
• Batch Records: Batch manufacturing and packaging records must be complete, accurate, and regularly reviewed. Every batch of drug product should have a traceable record of its entire production cycle.

5. Equipment Qualification and Calibration

• Qualification: Equipment should be appropriately qualified (Installation, Operational, and Performance Qualification) before use.
• Calibration: Regular calibration schedules should be maintained for all critical equipment, with documented proof of compliance.

6. Raw Materials and Supply Chain

• Material Receipt and Storage: Ensure proper procedures for receiving, inspecting, and storing raw materials to prevent contamination or degradation.
• Supplier Qualification: Verify that raw material suppliers are qualified and assessed regularly for compliance with GMP standards.
• Labeling and Traceability: Raw materials must be labeled correctly, and records should allow traceability through the entire supply chain.

7. Validation and Process Controls

• Process Validation: Verify that manufacturing processes are validated to consistently produce products that meet predetermined specifications.
• Critical Control Points: Identify and inspect the control of critical parameters like temperature, pressure, and mixing times.
• In-Process Testing: Evaluate procedures for in-process testing, ensuring it is conducted to prevent errors or deviations during manufacturing.

8. Environmental Monitoring and Contamination Control

• Environmental Monitoring: Ensure regular testing and monitoring of air quality, water, and surfaces to detect any potential contamination.
• Cleanrooms and Controlled Areas: Ensure proper maintenance of air filtration systems (HEPA filters), pressure differentials, and cleanliness in controlled areas.
• Microbial Testing: Inspect microbial monitoring procedures for both personnel and the environment.

9. Product Testing and Release

• Quality Control (QC) Testing: Finished products should undergo quality control testing (chemical, physical, and microbiological) to ensure they meet specifications.
• Release Criteria: Check the criteria for releasing products for sale, ensuring that they meet all necessary quality requirements and are approved by qualified personnel.
• Retention Samples: Inspect retention sample practices to ensure adequate storage and traceability for future reference.

10. Handling of Complaints and Recalls

• Complaint Handling: Ensure there is a robust system in place for handling and investigating product complaints.
• Product Recalls: Check if the facility has clear procedures for initiating, managing, and documenting product recalls if necessary.

11. Data Integrity

• Electronic and Paper Records: Inspect the management of electronic and paper records to ensure data integrity (no unauthorized changes, complete audit trails, etc.).
• Audit Trails: For electronic systems, verify that audit trails are in place to track changes to critical data.
• Archiving: Ensure proper storage and accessibility of records, including backups, for the required retention period.

12. Packaging and Labeling Controls

• Labeling Accuracy: Ensure that labels accurately reflect the product contents and regulatory information.
• Packaging Integrity: Inspect packaging to ensure it is designed to protect the product from contamination or damage and prevent counterfeiting.
• Segregation: Ensure that different products, including different strengths or forms, are clearly segregated to avoid mix-ups.

13. Storage and Distribution

• Storage Conditions: Verify that storage areas are climate-controlled as required for specific drug products (temperature, humidity, etc.).
• Distribution Practices: Inspect the facility’s distribution practices to ensure products are transported in compliance with their storage requirements and tracked for traceability.

14. Handling of Deviations and OOS (Out of Specification) Results

• Deviations: Evaluate how the facility handles deviations from standard processes, ensuring proper documentation, root cause analysis, and corrective actions.
• Out of Specification (OOS) Investigations: Check procedures for investigating OOS results, including root cause analysis and risk assessments.

15. Waste Disposal and Environmental Impact

• Waste Management: Inspect how the facility handles and disposes of hazardous waste and ensures that it does not contaminate the environment or the product.
• Environmental Impact: Evaluate the facility's procedures to mitigate any environmental impacts, such as emissions or water discharge.

16. Security and Restricted Access

• Access Controls: Inspect controls to restrict access to production, storage, and quality control areas to authorized personnel only.
• Security Systems: Ensure the facility has appropriate security measures (e.g., cameras, alarms) to prevent tampering or theft of products.

By focusing on these areas during a GMP inspection, you can ensure that the facility meets regulatory requirements, ensuring the safety, efficacy, and quality of the drugs being produced.

Contact information

Mail: turk.avci@gmail.com

Linkedin profile: Murat Avcı | LinkedIn